PRF Technologies (PRFX) Net Cash Flow (2020 - 2024)
PRF Technologies' (PRFX) quarterly Net Cash Flow came in at $3.5 million in Q2 2024, up 217.38% YoY from $1.1 million in Q3 2023, and up 195.22% on a QoQ basis from -$3.7 million in Q1 2024.
PRF Technologies (PRFX) Net Cash Flow (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Net Cash Flow data on file, last reported at $3.5 million in Q2 2024.
- Quarterly Net Cash Flow rose 217.38% year-over-year to $3.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 1107.19% YoY) and the FY2025 annual result came in at -$1.1 million, up 70.33% from the prior year.
- Net Cash Flow rose to $3.5 million in Q2 2024, from -$3.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $12.2 billion in Q3 2021 to a low of -$12.2 billion in Q4 2021.
- A 5-year average of $389166.7 and a median of -$661500.0 in 2020 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 71185.66% in 2021, down 605096.19% in 2021.
- Tracing PRFX's Net Cash Flow over 5 years: stood at -$2.0 million in 2020, then plunged by 605096.19% to -$12.2 billion in 2021, then soared by 99.98% to -$2.8 million in 2022, then soared by 116.51% to $469000.0 in 2023, then soared by 651.6% to $3.5 million in 2024.
- The last three Net Cash Flow figures came in at $3.5 million (Q2 2024), -$3.7 million (Q1 2024), and $469000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.61 Bn | 39.96 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.06 Bn | 19.39 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | PRF Technologies | 649,787.32 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 469,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |